MSAB-B.ST(MSAB-B.ST)
MSAB-B.ST
No analyst ratings available
No analyst price targets available for MSAB-B.ST
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $541M | $614M | $688M |
| Low | $540M | $612M | $686M |
| High | $541M | $615M | $689M |
| EBITDA Avg | $131M | $149M | $167M |
| Low | $131M | $149M | $166M |
| High | $131M | $149M | $167M |
| EBIT Avg | $110M | $125M | $140M |
| Low | $110M | $124M | $139M |
| High | $110M | $125M | $140M |
| Net Income Avg | $63M | $83M | $108M |
| Low | $62M | $79M | $101M |
| High | $63M | $85M | $110M |
| EPS Avg | $3.38 | $4.43 | $5.73 |
| Low | $3.35 | $4.28 | $5.49 |
| High | $3.42 | $4.58 | $5.97 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $151M | $166M |
| Low | $146M | $161M |
| High | $156M | $170M |
| EBITDA Avg | $37M | $40M |
| Low | $35M | $39M |
| High | $38M | $41M |
| EBIT Avg | $31M | $34M |
| Low | $30M | $33M |
| High | $32M | $35M |
| Net Income Avg | $30M | $32M |
| Low | $28M | $31M |
| High | $31M | $33M |
| EPS Avg | $1.60 | $1.73 |
| Low | $1.54 | $1.66 |
| High | $1.67 | $1.80 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 |